Abo incompatibility as a predictive marker in allogeneic peripheral blood stem cell transplantation from a fully matched sibling donor / Mai Abdelbassier Khalil ; Supervised Hossam Mohamed Kamel , Raafat Mohamed Abdelfattah , Ahmed Magdy Rabea
Material type: TextLanguage: English Publication details: Cairo : Mai Abdelbassier Khalil Atya , 2017Description: 98 P. : charts , facsimiles ; 25cmOther title:- كعلا{uئإإ٣}{uئإ٩٤} {uئإ٩٧}{uئإإ٨}{uئإ٩٢}{uئإ٨٦}{uئإئ٣}{uئإ٩٤} فى زرع ا{uئإؤئ}{uئإء٨}{uئإئأ}{uئإئ٣}{uئإ٨إ} ا{uئإؤئ}{uئإء٠}{uئإءأ}{uئإأآ}{uئإئ٤}{uئإ٩٤} ا{uئإؤئ}{uئإأ٤}{uئإءإ}{uئإؤ٣}{uئإئ٤}{uئإ٩٤} {uئإإ٣}{uئإإ٦} ا{uئإئ٧}{uئإء٧}{uئإإإ}ة ا{uئإؤئ}{uئإإ٤}{uئإ٩٨}{uئإأ٤}{uئإ٨إ}{uئإ٩١}{uئإؤ٨}{uئإئ٤}{uئإإ٦} {uئإ٩٧}{uئإإ٤}{uئإ٨إ}{uئإإ٣}ا ABO {uFECB}{uFEAA}م {uئإ٩٧}{uئإإإ}ا{uئإؤ٣}{uئإؤ٦} {uئإؤ٣}{uئإآأ}{uئإ٨إ}{uئإ٨آ}{uئإؤإ} ا{uئإؤئ}{uئإءء}م [Added title page title]
- Issued also as CD
Item type | Current library | Home library | Call number | Copy number | Status | Date due | Barcode | |
---|---|---|---|---|---|---|---|---|
Thesis | قاعة الرسائل الجامعية - الدور الاول | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.19.04.M.Sc.2017.Ma.A (Browse shelf(Opens below)) | Not for loan | 01010110073054000 | |||
CD - Rom | مخـــزن الرســائل الجـــامعية - البدروم | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.19.04.M.Sc.2017.Ma.A (Browse shelf(Opens below)) | 73054.CD | Not for loan | 01020110073054000 |
Thesis (M.Sc.) - Cairo University - National Cancer Institute - Department of Oncology-Medical
Background: Hematopoietic stem cell transplantation is a curative procedure for various hematological cancers as well as benign diseases. HLA-typing is essential before transplantation for the success of the procedure, however, nearly more than one half of transplants involve recipient-donor ABO incompatibility with subsequent increased risk for hemolytic reactions, delayed engraftment and pure red cell aplasia. Objective: The objective of this study was to determine the effect of ABO incompatibility on the outcome of allogeneic stem cell transplantation including the incidence of hemolysis, frequency of blood transfusion, engraftment and hospital stay. Patients and methods: This retrospective study was conducted at the bone marrow transplant unit in Nasser Institute. The study included patients with hematological malignancies transplanted from a fully HLA- matched donor in the period from January 2008 till September 2016. Conclusions: In this study there was no significant statistical difference between the ABO compatible and incompatible groups regarding mortality, acute graft versus host disease, number of blood and platelet transfusion and hospital stay
Issued also as CD
There are no comments on this title.